CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Metastatic Castration-Resistant Prostate Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
Business Management Videos
Sequencing Therapy With ADT Combinations
Raoul S. Concepcion, MD, FACS; Neal D. Shore, MD, FACS; Daniel George, MD; and Alec Koo, MD, consider implementing a treatment pathway and sequencing therapy when treating newly diagnosed metastatic prostate cancer with androgen deprivation therapy in combination with other options.
Redefining Advanced Prostate Cancer with Novel Imaging
Role of Molecular Testing in CRC Management
Johanna C. Bendell, MD; Cathy Eng, MD, FACP; John L. Marshall, MD; Michael A. Morse, MD; and Dale R. Shepard, MD, PhD, FACP, provide an overview of potential biomarkers in colorectal cancer, and discuss the role of molecular testing in predicting treatment response.
Colorectal Cancer: Individualizing Treatment, Improving Outcomes
Biomarkers for Selection of Immuno-Oncology Agents in NSCLC
Benjamin P. Levy, MD; Hossein Borghaei, DO, MS; Suresh S. Ramalingam, MD; and Roy S. Herbst, MD, PhD, deliberate on the use of PD-L1 expression and tumor mutational burden to deliver personalized immuno-oncology approaches to patients with newly diagnosed non–small cell lung cancer.
Practice Changing Trials in Advanced Non-Small Cell Lung Cancer
Dr. Wong on Anti-Amyloid Fibril Treatments in AL Amyloidosis
Sandy Wong, MD, assistant professor, University of California, San Francisco School of Medicine, discusses anti-amyloid fibril treatments, a class of agents that have yet to receive FDA approval in the treatment of patients with immunoglobulin light chain amyloidosis (AL amyloidosis).
Dr. Lagunes on Potential Combinations in the Treatment of Patients With NETs
Diane Reidy Lagunes, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses ongoing clinical trials and recent approvals that will shape the standard of care in the treatment of patients with neuroendocrine tumors (NETs).
Dr. Abou-Alfa on Sequencing Agents in the Treatment of Patients With HCC
Ghassan K. Abou-Alfa, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses how the potential approval of cabozantinib (Cabometyx) in hepatocellular carcinoma (HCC) could affect the treatment landscape in liver cancer.
Novel Agents in FL: Unmet Needs and Potential Uses
Ian W. Flinn, MD, PhD; Anas Younes, MD; Loretta J. Nastoupil, MD; Peter Martin, MD, MS; and Grzegorz S. Nowakowski, MD, share their insights concerning therapies that are on the horizon and discuss the need for an effective biomarker for follicular lymphoma.
Refining Therapeutic Strategies for Follicular Lymphoma
Dr. Bauml Discusses Biomarkers in Head and Neck Cancer
Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses biomarker development for patients with head and neck cancer.
MONARCH 3: Abemaciclib With Endocrine Therapy for mBC
Hope S. Rugo, MD, describes the exciting data from the MONARCH 3 trial looking at abemaciclib combined with letrozole or anastrozole for patients with hormone receptor-positive metastatic breast cancer; the combination markedly improved progression-free survival over an aromatase inhibitor alone.
CDK4/6 Inhibitors for Hormone-Driven Breast Cancer
Varying Pertinence: MRD Testing Across Lymphomas
Michael L. Wang, MD, discusses the value of monitoring minimal residual disease across various lymphoid malignancies.
Minimal Residual Disease Assessment in Lymphoid Malignancies
Next Page >>
Burden of Cardiovascular Disease in Prostate Cancer
The Role of Patient Education in Side Effect Management
Sorting Through the Alphabet Soup of Evolving Treatments in CLL
FDA Warns Against Single-Agent Checkpoint Inhibition for PD-L1-Low Untreated Urothelial Carcinoma
Will Precision Medicine Displace the Randomized Trial?
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.